Evidence map›Paper›PMID 36807529›Full record

ArticleMolecular oncology2023

Bicarbonate transport as regulator of antitumour immunity in pancreatic cancer.

Emily J Kay, Sara Zanivan

Open access · goldAbstract readComment
In one paragraph

Article in Molecular oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Emily J KayCancer Research UK Beatson Institute, Glasgow, UK.
Sara ZanivanCancer Research UK Beatson Institute, Glasgow, UK.ORCID 0000-0002-9880-9099
Cancer Research UK · GBCancer Research UK Scotland Institute · GB

Funding

Breast Cancer Now 2018NovPR102Cancer Research UK 29800Cancer Research UK A29800
6 · The paper itself

Abstract

Bicarbonate transport is a pre-existing mechanism of pH regulation in pancreatic ductal cells. In a recent study, Cappellesso et al. demonstrated that pancreatic ductal adenocarcinoma metabolic rewiring creates an acidic environment, enhanced by bicarbonate import into cancer cells via SLC4A4. This acidity favours protumourigenic immunosuppression. Targeting SLC4A4 neutralises environmental pH and restores antitumour immunity, sensitising tumours to immune checkpoint blockade.

Indexed as

Carcinoma, Pancreatic DuctalPancreatic NeoplasmsBicarbonatesHumansImmune ToleranceImmunotherapyTumor MicroenvironmentBicarbonatesacidosiscancerimmunotherapymetabolismT-cellstumour microenvironment

Identifiers

PMID36807529
PMCPMC10061281
OpenAlexW4321444549

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.